Cover Image
市場調查報告書

非精原細胞瘤睪丸癌:全球臨床實驗趨勢

Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 329073
出版日期 內容資訊 英文 66 Pages
訂單完成後即時交付
價格
Back to Top
非精原細胞瘤睪丸癌:全球臨床實驗趨勢 Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015
出版日期: 2015年03月27日 內容資訊: 英文 66 Pages
簡介

本報告提供全球非精原細胞瘤睪丸癌治療藥臨床實驗相關調查,提供您各地區的臨床實驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗等資料。

簡介

  • 非精原細胞瘤睪丸癌
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:腫瘤治療藥臨床實驗上非精原細胞瘤睪丸癌的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:腫瘤治療藥臨床實驗上非精原細胞瘤睪丸癌的比例

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的藥劑

  • 有代表性的研究機關·醫院臨床實驗概要
    • Memorial Sloan Kettering Cancer Center
    • National Cancer Institute
    • Abramson Cancer Center
    • Cambridge University Hospitals NHS Foundation Trust
    • City of Hope
    • Deutsche Krebshilfe e.V.
    • European Organization for Research and Treatment of Cancer
    • Indiana University School of Medicine
    • Institute of Cancer Research
    • Masonic Cancer Center

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2601CTIDB

GlobalData's clinical trial report, "Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015" provides data on the Nonseminomatous Testicular Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nonseminomatous Testicular Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nonseminomatous Testicular Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Nonseminomatous Testicular Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Nonseminomatous Testicular Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Drugs
  • Clinical Trial Overview of Top Institutes / Government
    • Memorial Sloan Kettering Cancer Center
    • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
    • National Cancer Institute
    • Clinical Trial Overview of National Cancer Institute
    • Abramson Cancer Center
    • Clinical Trial Overview of Abramson Cancer Center
    • Cambridge University Hospitals NHS Foundation Trust
    • Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust
    • City of Hope
    • Clinical Trial Overview of City of Hope
    • Deutsche Krebshilfe e.V.
    • Clinical Trial Overview of Deutsche Krebshilfe e.V.
    • European Organization for Research and Treatment of Cancer
    • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
    • Indiana University School of Medicine
    • Clinical Trial Overview of Indiana University School of Medicine
    • Institute of Cancer Research
    • Clinical Trial Overview of Institute of Cancer Research
    • Masonic Cancer Center
    • Clinical Trial Overview of Masonic Cancer Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Region, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Nonseminomatous Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Nonseminomatous Testicular Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cambridge University Hospitals NHS Foundation Trust, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Deutsche Krebshilfe e.V., 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Cancer Research, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2015*

List of Figures

  • Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Nonseminomatous Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Nonseminomatous Testicular Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top